Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 5NETWORK 2OTHER_GOV 1NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms, Plasma Cell 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1Hematologic Diseases 1Burkitt Lymphoma 1

Interventions

fludarabine phosphate 1fludarabine 1Injections 1Cyclophosphamide 1COVID-19 Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Hematologic Diseases × fludarabine phosphate × Clear all
NCT05755854 2023-09-22

Allogeneic γ9δ2 T Cells Treatment of Recurrent Hematologic Tumors

Anhui Provincial Hospital

Phase 1 Unknown
10 enrolled

Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡